US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

63.29

-0.5123-0.80%

Post-market: 63.290.00000.00%19:54 EDT

Volume:33.66K

Turnover:2.15M

Market Cap:232.59M

PE:- -

High:64.97

Open:64.52

Low:63.29

Close:63.80

52wk High:70.85

52wk Low:35.43

Shares:3.68M

Float Shares:3.68M

Volume Ratio:1.14

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Grail announces FDA advisory committee meeting to review Galleri test PMA

Zentalis Q2 Net Loss Widens on Higher R&D Costs

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

TriSalus Life Sciences Q2 Revenue Beats Estimates

Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26

Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million

Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million

THOMSON REUTERS

Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029

THOMSON REUTERS

Xenon Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS

CG Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

CG Oncology Publishes Investor Deck Highlighting Cretostimogene Data in High-Risk NMIBC Programs

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS

CG Oncology Q2 EPS USD -0.9

THOMSON REUTERS

CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing

THOMSON REUTERS

Market Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition

MT Newswires Live

Abbvie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg News

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/SBIO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":63.29,"timestamp":1789156800000,"preClose":63.8023,"halted":0,"volume":33663,"hourTrading":{"tag":"盘后","latestPrice":63.29,"preClose":63.29,"latestTime":"19:54 EDT","volume":15,"amount":948.49,"timestamp":1789170887116,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008029491099850685,"floatShares":3675000,"shares":3675000,"eps":0,"marketStatus":"Market Closed","change":-0.5123,"latestTime":"09-11 16:00:00 EDT","open":64.52,"high":64.97,"low":63.29,"amount":2148865.385331,"amplitude":0.026331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":63.8023,"sharesOutstanding":2675000,"nav":63.86,"aum":234685289.26,"bidAskSpread":0.002338,"postHourTrading":{"tag":"盘后","latestPrice":63.29,"preClose":63.29,"latestTime":"19:54 EDT","volume":15,"amount":948.49,"timestamp":1789170887116,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.136864,"impliedVol":0.3516,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3675000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.136864,"shares":3675000,"dividePrice":0,"high":64.97,"amplitude":0.026331,"preClose":63.8023,"low":63.29,"week52Low":35.43,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":63.29,"eps":0,"divideRate":0,"volume":33663,"delay":0,"ttmEps":0,"open":64.52,"prevYearClose":51.22,"prevWeekClose":67.66,"prevMonthClose":66.82,"prevQuarterClose":64.65,"fiveDayClose":67.31,"twentyDayClose":66.92,"sixtyDayClose":53.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","GRAL","BK4585","FBT","IBRN","BK4129","XBIX","BK4139","BBP","BK4588","LABU","PMA","PBE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666539","title":"Zentalis Q2 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666539","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666539?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:36","pubTimestamp":1786052164,"startTime":"0","endTime":"0","summary":"Zentalis Q2 net loss widens on higher R&D costsOverviewOncology drug developer's Q2 net loss widened as R&D expenses rose on trial milestonesCompany completed enrollment in DENALI Part 2a and 2b, adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL","CGON","BK4139","ALXO","REPL","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657066508","title":"Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657066508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657066508?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:20","pubTimestamp":1786051212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InflaRx (IFRX), CG Oncology, Inc. (CGON) and Edgewis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inflarx-ifrx-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inflarx-ifrx-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IFRX","CGON","BK4135","HCSG","BK4585","IE00B64PRP62.GBP","XBI","GPZ","IE00B3QW5Z07.USD","BK4581","SBIO","BK4139","CG","LABU","IE00BGHQF748.EUR","BK4137","BK4588","XLV","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657080663","title":"Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657080663","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657080663?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050101,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings SummaryXenon Pharmaceuticals Inc.XENE.OQreported a quarterly adjusted loss of $1.11 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433E4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SBIO","XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689246","title":"TriSalus Life Sciences Q2 Revenue Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689246","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657689246?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:32","pubTimestamp":1786048347,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Q2 revenue beats estimatesOverviewOncology device maker's Q2 revenue rose yr/yr, beating analyst expectationsCompany maintained 2026 revenue guidance of $54 mln to $57 mlnOperat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS","BK4082","DCTH","TLSI","SBIO","CGON","BK4535","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650667","title":"Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650667","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650667?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:16","pubTimestamp":1786047402,"startTime":"0","endTime":"0","summary":"Biopharma firm IN8bio's Q2 net loss narrows as expenses declineOverviewUS biopharma firm's Q2 net loss narrowed yr/yr, with flat R&D and lower G&A expensesCompany reported updated clinical data showin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","BK4539","CGON","INAB","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650887","title":"Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650887","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650887?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:14","pubTimestamp":1786047240,"startTime":"0","endTime":"0","summary":"Canada's Xenon Pharma Q2 net loss widens on higher expensesOverviewCanada neuroscience drug developer's Q2 net loss widened and missed analyst expectationsHigher R&D and administrative costs drove the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0823416689.USD","XENE","GHRS","BK4007","LU2065171402.SGD","LU2065171311.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","PSIL","IBRN","SBIO","IE0002141913.USD","LU2065170008.USD","LU2065169927.USD","BK4563","PRAX","LU0154245756.USD","IE00BJJMRZ35.SGD","LU0154245673.USD","LU0320765992.SGD","LU2324357040.USD","BK4539","IE00BJT1NW94.SGD","BK4139","IMRX","LU0109394709.USD","IE0009355771.USD","NBIX","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571056","title":"Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571056","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571056?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:07","pubTimestamp":1786046831,"startTime":"0","endTime":"0","summary":"Xenon net loss widens 30.7% to $110.74 million in Q2 FY26Xenon posted a Q2 net loss of USD 110.7 million, widening from USD 84.7 million a year earlier.R&D costs rose to USD 99.2 million from USD 75 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLbgCR29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IBRN","SBIO","BCDF","LU0314104364.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014005.SGD","BK4112","IE00BN0W2W23.USD","SG9999014013.SGD","LU2095319765.USD","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","BK4139","BK4588","XENE","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657365271","title":"Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657365271","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657365271?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046521,"startTime":"0","endTime":"0","summary":"BRIEF-Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 MillionAug 06 (Reuters) - Xenon Pharmaceuticals Q2 income from operations USD -123.155 million.Q2 operating expenses USD 123.155 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE","IBRN","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652480","title":"Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652480?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","BK4139","XENE","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521606","title":"Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521606?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","SBIO","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465223","title":"Xenon Reports Q2 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465223?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA4YCGCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","BK4139","XENE","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657763093","title":"CG Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657763093","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657763093?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:21","pubTimestamp":1786026089,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. reports results for the quarter ended June 30 - Earnings SummaryCG Oncology, Inc.CGON.OQreported a quarterly adjusted loss of 90 cents per share for the quarter ended June 30, lower ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N44329Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657263440","title":"CG Oncology Publishes Investor Deck Highlighting Cretostimogene Data in High-Risk NMIBC Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657263440","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657263440?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:04","pubTimestamp":1786021455,"startTime":"0","endTime":"0","summary":"CG Oncology publishes investor deck highlighting cretostimogene data in high-risk NMIBC programsCG Oncology highlighted Phase 3 BOND-003 Cohort C in high-risk BCG-unresponsive CIS, reporting 76% compl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8wxmhj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063925","title":"CG Oncology Q2 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063925","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063925?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:22","pubTimestamp":1786018956,"startTime":"0","endTime":"0","summary":"CG Oncology Q2 net loss widens on higher R&D costsOverviewUS biopharmaceutical firm's Q2 rev rose to $1.2 mln, reflecting early commercialization activityNet loss widened to $79.1 mln, driven by highe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CMPX","AVTX","BK4139","CHRS","BK4535","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639609","title":"CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639609?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:15","pubTimestamp":1786018501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA70KC8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657396066","title":"CG Oncology Q2 EPS USD -0.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2657396066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657396066?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:15","pubTimestamp":1786018500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHMKD13:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657263613","title":"CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657263613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657263613?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:02","pubTimestamp":1786017778,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633115","title":"Market Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633115?lang=en_us&edition=fundamental","pubTime":"2026-08-05 01:40","pubTimestamp":1785865235,"startTime":"0","endTime":"0","summary":"AbbVie  has commenced a $10 billion investment-grade bond sale to help finance its pending acquisition of Apogee Therapeutics , Bloomberg reported Tuesday, citing people with direct knowledge of the matter.The offering, which includes bonds maturing in two to 40 years, has drawn about $63 billion of peak demand, the report said, citing the people.AbbVie didn't immediately reply to a request for comment from MT Newswires.Price: 243.24, Change: -1.86, Percent Change: -0.76","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JDOC","US7Y.BOND","LU1244550221.USD","LU1162221912.USD","VHT","LU0943347566.SGD","US10Y.BOND","MEDX","US6M.BOND","PJP","LU0310799852.SGD","LU1585245621.USD","LU1093756168.USD","LU0912757837.SGD","TMF","IXJ","LU0738911758.USD","US2Y.BOND","AGNG","SBIO","TLT","IYH","LU2087621335.USD","FHLC","GLAM","LU0511384066.AUD","US3Y.BOND","IE00BJJMRZ35.SGD","LU0395794307.EUR","LU1267930490.SGD","ABBV","TLTW","FTXH","LU1923622614.USD","US12M.BOND","TRUH","LU1551013342.USD","US5Y.BOND","LU2347655073.USD","RXL","XLV","IE00BVYPNV92.GBP","US30Y.BOND","LU1934455863.HKD","LU1037948541.HKD","APGE","LU0211328371.USD","LU0203345920.USD","LU0859254822.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590975","title":"Abbvie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590975?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:17","pubTimestamp":1785849448,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4410VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739343.SGD","IE00B42XCP33.USD","LU0029864427.USD","LU0058720904.USD","LU0198837287.USD","SG9999015952.SGD","IE00BFTCPJ56.SGD","MEDX","LU2237443622.USD","GLAM","LU1989771016.USD","IXJ","LU0820561909.HKD","TRUH","IE00BVYPNW00.USD","LU0661504455.SGD","RXL","LU1551013342.USD","LU1244550494.USD","LU0122379950.USD","LU0726765562.USD","LU0203347892.USD","IYH","LU2468319806.SGD","LU1551013425.SGD","LU1670628061.USD","ABBV","LU2125909593.SGD","XLV","FTXH","FHLC","IE00BDGV0183.EUR","SBIO","JDOC","AGNG","LU2433249047.HKD","PPH","LU0861579265.USD","LU2357627491.SGD","LU0289961442.SGD","PJP","LU0053671581.USD","LU2089284900.SGD","APGE","VHT","LU0965508806.USD","SG9999003800.SGD","LU0211328371.USD","LU1093756325.SGD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":86,"code":"91000000","status":"200"}]}}